Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:19
09/13/21
09/13
12:19
09/13/21
12:19
KSU

Kansas City Southern

$281.58 /

+1.33 (+0.47%)

, CNI

Canadian National

$117.70 /

-1.2 (-1.01%)

, CP

Canadian Pacific

$68.49 /

-0.07 (-0.10%)

, WMT

Walmart

$145.09 /

-0.83 (-0.57%)

, MMM

3M

$186.35 /

+1.83 (+0.99%)

, SPCE

Virgin Galactic

$24.58 /

-0.58 (-2.31%)

, DVAX

Dynavax

$15.10 /

-2.46 (-14.01%)

, PFE

Pfizer

$44.54 /

-1.05 (-2.30%)

, BABA

Alibaba

$166.01 /

-2.05 (-1.22%)

, QCOM

Qualcomm

$142.27 /

-0.34 (-0.24%)

, VNE

Veoneer

$35.77 /

+0.925 (+2.65%)

, CG

Carlyle Group

$49.40 /

+0.56 (+1.15%)

, INTC

Intel

$54.72 /

+0.87 (+1.62%)

, LPTX

Leap Therapeutics

$1.71 /

+0.245 (+16.72%)

, ATER

Aterian

$16.37 /

+4.585 (+38.91%)

, NSSC

Napco Security

$42.35 /

+4.33 (+11.39%)

, FAMI

Farmmi

/

+

, CRWD

Crowdstrike

$250.78 /

-11.18 (-4.27%)

, NUVA

NuVasive

$57.69 /

-0.03 (-0.05%)

, AGIL

AgileThought

$11.40 /

-0.58 (-4.84%)

, ABCM

Abcam

$20.21 /

-0.665 (-3.19%)

, ASGTF

Altus Group

$51.63 /

+ (+0.00%)

, NEGG

Newegg Commerce

$18.17 /

+0.72 (+4.13%)

, NKE

Nike

$159.75 /

-3.85 (-2.35%)

, TWTR

Twitter

$59.13 /

-2.44 (-3.96%)

, ABNB

Airbnb

$160.03 /

-5.08 (-3.08%)

, CHKP

Check Point

$118.35 /

-2.69 (-2.22%)

, NGM

NGM Biopharmaceuticals

$26.80 /

+3.45 (+14.78%)

, DELL

Dell Technologies

$98.70 /

+3.47 (+3.64%)

, $LTC

Litecoin

/

+

Get caught up quickly on…

ShowHide Related Items >><<
WMT Walmart
$145.09 /

-0.83 (-0.57%)

VNE Veoneer
$35.77 /

+0.925 (+2.65%)

TWTR Twitter
$59.13 /

-2.44 (-3.96%)

SPCE Virgin Galactic
$24.58 /

-0.58 (-2.31%)

QCOM Qualcomm
$142.27 /

-0.34 (-0.24%)

PFE Pfizer
$44.54 /

-1.05 (-2.30%)

NUVA NuVasive
$57.69 /

-0.03 (-0.05%)

NKE Nike
$159.75 /

-3.85 (-2.35%)

NGM NGM Biopharmaceuticals
$26.80 /

+3.45 (+14.78%)

NEGG Newegg Commerce
$18.17 /

+0.72 (+4.13%)

MMM 3M
$186.35 /

+1.83 (+0.99%)

LPTX Leap Therapeutics
$1.71 /

+0.245 (+16.72%)

KSU Kansas City Southern
$281.58 /

+1.33 (+0.47%)

INTC Intel
$54.72 /

+0.87 (+1.62%)

FAMI Farmmi
/

+

DVAX Dynavax
$15.10 /

-2.46 (-14.01%)

DELL Dell Technologies
$98.70 /

+3.47 (+3.64%)

CRWD Crowdstrike
$250.78 /

-11.18 (-4.27%)

CNI Canadian National
$117.70 /

-1.2 (-1.01%)

CHKP Check Point
$118.35 /

-2.69 (-2.22%)

CG Carlyle Group
$49.40 /

+0.56 (+1.15%)

BABA Alibaba
$166.01 /

-2.05 (-1.22%)

ATER Aterian
$16.37 /

+4.585 (+38.91%)

ASGTF Altus Group
$51.63 /

+ (+0.00%)

AGIL AgileThought
$11.40 /

-0.58 (-4.84%)

ABNB Airbnb
$160.03 /

-5.08 (-3.08%)

ABCM Abcam
$20.21 /

-0.665 (-3.19%)

$LTC Litecoin
/

+

KSU Kansas City Southern
$281.58 /

+1.33 (+0.47%)

09/08/21 Deutsche Bank
Canadian National shares not 'overly compelling' after rally, says Deutsche Bank
09/01/21
Fly Intel: Top five analyst downgrades
09/01/21 Loop Capital
Canadian National, Kansas City Southern cut to Hold at Loop Capital
09/01/21 Citi
Citi upgrades Canadian National to Buy on operating ratio refocus
CNI Canadian National
$117.70 /

-1.2 (-1.01%)

09/07/21 CIBC
Canadian National price target raised to C$170 from C$158 at CIBC
09/01/21
Fly Intel: Top five analyst upgrades
CP Canadian Pacific
$68.49 /

-0.07 (-0.10%)

08/12/21 Argus
Canadian Pacific downgraded to Hold from Buy at Argus
08/12/21 Argus
Canadian Pacific downgraded to Hold from Buy at Argus
07/29/21 CIBC
Canadian Pacific price target raised to C$106 from C$105 at CIBC
WMT Walmart
$145.09 /

-0.83 (-0.57%)

08/30/21 Credit Suisse
Amazon deal could add 35%-40% to Affirm contribution profit, says Credit Suisse
08/27/21 Tigress Financial
Walmart valuation limits outperformance potential, says Tigress Financial
08/18/21 Cowen
Walmart price target raised to $175 from $170 at Cowen
08/18/21 DA Davidson
Walmart's Q2 results should support stock gains, says DA Davidson
MMM 3M
$186.35 /

+1.83 (+0.99%)

07/28/21 Argus
3M price target raised to $225 from $220 at Argus
07/28/21 Deutsche Bank
3M price target raised to $201 from $196 at Deutsche Bank
07/14/21 Deutsche Bank
3M price target lowered to $196 from $199 at Deutsche Bank
07/12/21 Wolfe Research
3M downgraded to Underperform on weakening end markets at Wolfe Research
SPCE Virgin Galactic
$24.58 /

-0.58 (-2.31%)

09/08/21 Susquehanna
Virgin Galactic hopes FAA investigation resolved quickly, says Susquehanna
08/31/21
Fly Intel: Top five analyst initiations
08/31/21 Jefferies
Virgin Galactic initiated with a Buy at Jefferies
08/12/21
Fly Intel: Top five analyst downgrades
DVAX Dynavax
$15.10 /

-2.46 (-14.01%)

08/31/21 H.C. Wainwright
Dynavax price target raised to $23 from $20 at H.C. Wainwright
08/05/21 Goldman Sachs
Dynavax initiated with a Buy at Goldman Sachs
08/05/21 H.C. Wainwright
Dynavax price target raised to $20 from $16 at H.C. Wainwright
02/08/21 Evercore ISI
Dynavax had 'big vaccine update week,' says Evercore ISI
PFE Pfizer
$44.54 /

-1.05 (-2.30%)

09/13/21 JPMorgan
Pfizer price target raised to $42 from $40 at JPMorgan
09/09/21 SVB Leerink
SVB Leerink bullish on ContraFect, initiates with an Outperform
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21 Jefferies
Celcuity initiated with a Buy, $48 price target at Jefferies
BABA Alibaba
$166.01 /

-2.05 (-1.22%)

09/06/21 KGI Securities
Alibaba initiated with a Neutral at KGI Securities
08/20/21 Erste Group
Alibaba downgraded to Sell from Hold at Erste Group
08/05/21 Susquehanna
Alibaba price target lowered to $310 from $350 at Susquehanna
08/04/21 KeyBanc
Alibaba price target lowered to $250 from $270 at KeyBanc
QCOM Qualcomm
$142.27 /

-0.34 (-0.24%)

09/09/21 Tigress Financial
Qualcomm shares going to $195 in 12 months, says Tigress Financial
08/24/21 KeyBanc
Resilient July iPhone 12 sell-through bodes well for 13 launch, says KeyBanc
08/18/21 Credit Suisse
Veoneer upgraded to Neutral from Underperform at Credit Suisse
08/12/21 Canaccord
Qualcomm price target raised to $225 from $200 at Canaccord
VNE Veoneer
$35.77 /

+0.925 (+2.65%)

09/03/21 Danske Bank
Veoneer downgraded to Hold from Buy at Danske Bank
08/18/21
Fly Intel: Top five analyst upgrades
08/01/21 Evercore ISI
Veoneer upgraded to In Line from Underperform at Evercore ISI
CG Carlyle Group
$49.40 /

+0.56 (+1.15%)

09/13/21
Fly Intel: Top five analyst upgrades
09/13/21 BMO Capital
Carlyle Group upgraded to Outperform from Market Perform at BMO Capital
08/11/21 Deutsche Bank
Carlyle Group upgraded to Buy on durable earnings power at Deutsche Bank
08/11/21 Deutsche Bank
Carlyle Group upgraded to Buy from Hold at Deutsche Bank
INTC Intel
$54.72 /

+0.87 (+1.62%)

09/09/21 Lynx
Lynx expects Intel shares to 'move up somewhat' on CFO presentation
09/08/21 Deutsche Bank
Intel resumed with a Hold at Deutsche Bank
07/29/21 Argus
AMD price target raised to $120 from $106 at Argus
07/28/21 Jefferies
AMD remains a top pick at Jefferies, sees server share gains to accelerate
LPTX Leap Therapeutics
$1.71 /

+0.245 (+16.72%)

09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
06/03/21 Baird
Leap Therapeutics transferred with Outperform at Baird
05/17/21 Piper Sandler
Leap Therapeutics price target lowered to $4 from $6 at Piper Sandler
03/22/21 Piper Sandler
Leap data suggest DKN-01 likely providing clinical benefit, says Piper Sandler
ATER Aterian
$16.37 /

+4.585 (+38.91%)

08/10/21 DA Davidson
Aterian price target lowered to $7 from $42 at DA Davidson
08/10/21 Roth Capital
Aterian downgraded to Neutral at Roth Capital following Q2 miss
08/10/21 Roth Capital
Aterian downgraded to Neutral from Buy at Roth Capital
08/09/21 BTIG
Aterian price target lowered to $10 from $36 at BTIG
NSSC Napco Security
$42.35 /

+4.33 (+11.39%)

06/09/21 Needham
Napco Security assumed with a Buy at Needham
02/09/21 Lake Street
Napco Security price target raised to $35 from $29 at Lake Street
02/09/21 Canaccord
Napco Security price target raised to $34 from $30 at Canaccord
01/21/21 B. Riley
Napco announced 'significant win' of school project, says B. Riley
FAMI Farmmi
/

+

CRWD Crowdstrike
$250.78 /

-11.18 (-4.27%)

09/13/21
Fly Intel: Top five analyst downgrades
09/13/21 Goldman Sachs
Crowdstrike downgraded to Neutral from Buy at Goldman Sachs
09/09/21 Wells Fargo
SentinelOne price target raised to $80 from $55 at Wells Fargo
09/01/21 BTIG
Crowdstrike price target raised to $313 from $302 at BTIG
NUVA NuVasive
$57.69 /

-0.03 (-0.05%)

09/13/21 Piper Sandler
NuVasive 'hiccup' brings buying opportunity, says Piper Sandler
07/15/21 Piper Sandler
NuVasive MAGEC ship hold lift positive despite FDA warning, says Piper Sandler
05/06/21 Piper Sandler
NuVasive price target raised to $80 from $75 at Piper Sandler
04/27/21 Truist
NuVasive price target raised to $80 from $68 at Truist
AGIL AgileThought
$11.40 /

-0.58 (-4.84%)

ABCM Abcam
$20.21 /

-0.665 (-3.19%)

06/24/21 Berenberg
Abcam price target raised to 1,350 GBp from 1,300 GBp at Berenberg
03/12/21 Berenberg
Abcam price target raised to 1,300 GBp from 1,180 GBp at Berenberg
03/09/21 JPMorgan
Abcam price target lowered to 1,300 GBp from 1,400 GBp at JPMorgan
03/09/21 RBC Capital
Abcam price target lowered to 1,640 GBp from 1,750 GBp at RBC Capital
ASGTF Altus Group
$51.63 /

+ (+0.00%)

08/13/21 Scotiabank
Altus Group price target raised to C$61 from C$58 at Scotiabank
05/07/21 RBC Capital
Altus Group price target raised to C$68 from C$62 at RBC Capital
05/07/21 CIBC
Altus Group price target raised to C$58 from C$52.50 at CIBC
04/22/21 Canaccord
Altus Group price target raised to C$70 from C$59 at Canaccord
NEGG Newegg Commerce
$18.17 /

+0.72 (+4.13%)

NKE Nike
$159.75 /

-3.85 (-2.35%)

09/13/21 BTIG
BTIG downgrades Nike on 'severe supply chain disruptions' in Vietnam
09/13/21 BTIG
Nike downgraded to Neutral from Buy at BTIG
09/09/21 UBS
Nike more likely to rise than fall after Q1 results, says UBS
TWTR Twitter
$59.13 /

-2.44 (-3.96%)

09/13/21
Fly Intel: Top five analyst initiations
09/13/21 Goldman Sachs
Twitter initiated with a Sell at Goldman Sachs
09/09/21 JPMorgan
Netflix, Uber added as top U.S. Internet picks at JPMorgan
08/23/21 Arete
Arete sees 'various hurdles' for Twitter to hit 2023 sales target
ABNB Airbnb
$160.03 /

-5.08 (-3.08%)

09/13/21 Goldman Sachs
Airbnb initiated with a Sell at Goldman Sachs
CHKP Check Point
$118.35 /

-2.69 (-2.22%)

09/13/21 Goldman Sachs
Check Point downgraded to Sell from Neutral at Goldman Sachs
07/27/21 BMO Capital
Check Point price target raised to $140 from $135 at BMO Capital
07/27/21 Morgan Stanley
Check Point price target raised to $114 from $110 at Morgan Stanley
NGM NGM Biopharmaceuticals
$26.80 /

+3.45 (+14.78%)

09/12/21 Raymond James
NGM Biopharmaceuticals upgraded to Strong Buy from Outperform at Raymond James
09/10/21 B. Riley
Mixed data from Apellis supports NGM bull thesis, says B. Riley
09/10/21 Piper Sandler
Apellis data validation for NGM Biopharmaceuticals, says Piper Sandler
09/07/21 B. Riley
NGM Biopharmaceuticals price target raised to $35 from $32 at B. Riley
DELL Dell Technologies
$98.70 /

+3.47 (+3.64%)

09/13/21 Goldman Sachs
Dell Technologies upgraded to Conviction Buy from Buy at Goldman Sachs
08/31/21 Societe Generale
Dell Technologies price target lowered to $104 from $112 at Societe Generale
08/27/21 Raymond James
Dell Technologies price target lowered to $115 from $118 at Raymond James
$LTC Litecoin
/

+

06/03/21 Mizuho
LTC Properties downgraded to Underperform from Neutral at Mizuho
03/30/21 Capital One
LTC Properties downgraded to Equalweight from Overweight at Capital One
03/03/21 RBC Capital
LTC Properties price target raised to $38 from $33 at RBC Capital
02/09/21 Mizuho
LTC Properties price target raised to $38 from $35 at Mizuho
WMT Walmart
$145.09 /

-0.83 (-0.57%)

VNE Veoneer
$35.77 /

+0.925 (+2.65%)

TWTR Twitter
$59.13 /

-2.44 (-3.96%)

SPCE Virgin Galactic
$24.58 /

-0.58 (-2.31%)

QCOM Qualcomm
$142.27 /

-0.34 (-0.24%)

PFE Pfizer
$44.54 /

-1.05 (-2.30%)

NUVA NuVasive
$57.69 /

-0.03 (-0.05%)

NSSC Napco Security
$42.35 /

+4.33 (+11.39%)

NKE Nike
$159.75 /

-3.85 (-2.35%)

NGM NGM Biopharmaceuticals
$26.80 /

+3.45 (+14.78%)

NEGG Newegg Commerce
$18.17 /

+0.72 (+4.13%)

MMM 3M
$186.35 /

+1.83 (+0.99%)

LPTX Leap Therapeutics
$1.71 /

+0.245 (+16.72%)

KSU Kansas City Southern
$281.58 /

+1.33 (+0.47%)

INTC Intel
$54.72 /

+0.87 (+1.62%)

DVAX Dynavax
$15.10 /

-2.46 (-14.01%)

DELL Dell Technologies
$98.70 /

+3.47 (+3.64%)

CRWD Crowdstrike
$250.78 /

-11.18 (-4.27%)

CP Canadian Pacific
$68.49 /

-0.07 (-0.10%)

CNI Canadian National
$117.70 /

-1.2 (-1.01%)

CHKP Check Point
$118.35 /

-2.69 (-2.22%)

CG Carlyle Group
$49.40 /

+0.56 (+1.15%)

BABA Alibaba
$166.01 /

-2.05 (-1.22%)

ATER Aterian
$16.37 /

+4.585 (+38.91%)

ASGTF Altus Group
$51.63 /

+ (+0.00%)

AGIL AgileThought
$11.40 /

-0.58 (-4.84%)

ABNB Airbnb
$160.03 /

-5.08 (-3.08%)

ABCM Abcam
$20.21 /

-0.665 (-3.19%)

$LTC Litecoin
/

+

  • 19
    May
  • 22
    Mar
  • 12
    Mar
  • 06
    Jan
  • 11
    Dec
  • 10
    Dec
  • 22
    Oct
WMT Walmart
$145.09 /

-0.83 (-0.57%)

TWTR Twitter
$59.13 /

-2.44 (-3.96%)

SPCE Virgin Galactic
$24.58 /

-0.58 (-2.31%)

QCOM Qualcomm
$142.27 /

-0.34 (-0.24%)

PFE Pfizer
$44.54 /

-1.05 (-2.30%)

NKE Nike
$159.75 /

-3.85 (-2.35%)

NEGG Newegg Commerce
$18.17 /

+0.72 (+4.13%)

MMM 3M
$186.35 /

+1.83 (+0.99%)

KSU Kansas City Southern
$281.58 /

+1.33 (+0.47%)

INTC Intel
$54.72 /

+0.87 (+1.62%)

DELL Dell Technologies
$98.70 /

+3.47 (+3.64%)

CRWD Crowdstrike
$250.78 /

-11.18 (-4.27%)

CNI Canadian National
$117.70 /

-1.2 (-1.01%)

CHKP Check Point
$118.35 /

-2.69 (-2.22%)

CG Carlyle Group
$49.40 /

+0.56 (+1.15%)

BABA Alibaba
$166.01 /

-2.05 (-1.22%)

ABNB Airbnb
$160.03 /

-5.08 (-3.08%)

$LTC Litecoin
/

+

WMT Walmart
$145.09 /

-0.83 (-0.57%)

VNE Veoneer
$35.77 /

+0.925 (+2.65%)

TWTR Twitter
$59.13 /

-2.44 (-3.96%)

SPCE Virgin Galactic
$24.58 /

-0.58 (-2.31%)

QCOM Qualcomm
$142.27 /

-0.34 (-0.24%)

PFE Pfizer
$44.54 /

-1.05 (-2.30%)

NKE Nike
$159.75 /

-3.85 (-2.35%)

NGM NGM Biopharmaceuticals
$26.80 /

+3.45 (+14.78%)

NEGG Newegg Commerce
$18.17 /

+0.72 (+4.13%)

MMM 3M
$186.35 /

+1.83 (+0.99%)

LPTX Leap Therapeutics
$1.71 /

+0.245 (+16.72%)

KSU Kansas City Southern
$281.58 /

+1.33 (+0.47%)

INTC Intel
$54.72 /

+0.87 (+1.62%)

DVAX Dynavax
$15.10 /

-2.46 (-14.01%)

DELL Dell Technologies
$98.70 /

+3.47 (+3.64%)

CRWD Crowdstrike
$250.78 /

-11.18 (-4.27%)

CHKP Check Point
$118.35 /

-2.69 (-2.22%)

CG Carlyle Group
$49.40 /

+0.56 (+1.15%)

BABA Alibaba
$166.01 /

-2.05 (-1.22%)

ABNB Airbnb
$160.03 /

-5.08 (-3.08%)

$LTC Litecoin
/

+

WMT Walmart
$145.09 /

-0.83 (-0.57%)

VNE Veoneer
$35.77 /

+0.925 (+2.65%)

TWTR Twitter
$59.13 /

-2.44 (-3.96%)

SPCE Virgin Galactic
$24.58 /

-0.58 (-2.31%)

QCOM Qualcomm
$142.27 /

-0.34 (-0.24%)

PFE Pfizer
$44.54 /

-1.05 (-2.30%)

NKE Nike
$159.75 /

-3.85 (-2.35%)

NEGG Newegg Commerce
$18.17 /

+0.72 (+4.13%)

MMM 3M
$186.35 /

+1.83 (+0.99%)

KSU Kansas City Southern
$281.58 /

+1.33 (+0.47%)

INTC Intel
$54.72 /

+0.87 (+1.62%)

DVAX Dynavax
$15.10 /

-2.46 (-14.01%)

DELL Dell Technologies
$98.70 /

+3.47 (+3.64%)

CRWD Crowdstrike
$250.78 /

-11.18 (-4.27%)

CP Canadian Pacific
$68.49 /

-0.07 (-0.10%)

CNI Canadian National
$117.70 /

-1.2 (-1.01%)

BABA Alibaba
$166.01 /

-2.05 (-1.22%)

ATER Aterian
$16.37 /

+4.585 (+38.91%)

ABNB Airbnb
$160.03 /

-5.08 (-3.08%)

Earnings
NuVasive sees Q3 sales below Q2's $294.4M, consensus $302.55M » 09:59
09/13/21
09/13
09:59
09/13/21
09:59
NUVA

NuVasive

$57.42 /

-0.3 (-0.52%)

In a presentation to…

In a presentation to investors, NuVasive said it expects net sales in Q3 to be sequentially lower from Q2. "Some regions of the U.S. market have been more challenging than expected since 1H 2021 due to the impact of the COVID19 Delta variant and other factors," NuVasive noted. This is "likely to pressure margins" in Q3, the company added. NuVasive's Q2 net sales were $294.8M and the Q3 consensus estimate is $305.55M.

ShowHide Related Items >><<
NUVA NuVasive
$57.42 /

-0.3 (-0.52%)

NUVA NuVasive
$57.42 /

-0.3 (-0.52%)

09/13/21 Piper Sandler
NuVasive 'hiccup' brings buying opportunity, says Piper Sandler
07/15/21 Piper Sandler
NuVasive MAGEC ship hold lift positive despite FDA warning, says Piper Sandler
05/06/21 Piper Sandler
NuVasive price target raised to $80 from $75 at Piper Sandler
04/27/21 Truist
NuVasive price target raised to $80 from $68 at Truist
NUVA NuVasive
$57.42 /

-0.3 (-0.52%)

Recommendations
NuVasive 'hiccup' brings buying opportunity, says Piper Sandler » 09:51
09/13/21
09/13
09:51
09/13/21
09:51
NUVA

NuVasive

$57.27 /

-0.45 (-0.78%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien says Covid challenges in the U.S. have caused a slowdown in NuVasive's Q3, with sales in quarter now expected to be sequentially weaker than Q2 versus in line to slightly up previously. However, management still remains confident in its full year outlook, "and with the recent Pulse approval and a robust pipeline, we agree," O'Brien tells investors in a research note. Despite "this near term hiccup," there's "a lot to like about the long-term trajectory" for NuVasive, says the analyst. He thinks the news presents a good buying opportunity for patient investors and keeps an Overweight rating on NuVasive with an $80 price target.

ShowHide Related Items >><<
NUVA NuVasive
$57.27 /

-0.45 (-0.78%)

NUVA NuVasive
$57.27 /

-0.45 (-0.78%)

07/15/21 Piper Sandler
NuVasive MAGEC ship hold lift positive despite FDA warning, says Piper Sandler
05/06/21 Piper Sandler
NuVasive price target raised to $80 from $75 at Piper Sandler
04/27/21 Truist
NuVasive price target raised to $80 from $68 at Truist
04/05/21 Piper Sandler
FDA appears to approve NuVasive two-level indication, says Piper Sandler
NUVA NuVasive
$57.27 /

-0.45 (-0.78%)

Hot Stocks
NuVasive says not withdrawing 2021 guidance 'at this time' » 09:46
09/13/21
09/13
09:46
09/13/21
09:46
NUVA

NuVasive

$56.40 /

-1.32 (-2.29%)

NuVasive said today in an…

NuVasive said today in an investor presentation, "Not withdrawing or updating full-year 2021 guidance at this time; will continue to monitor and assess."

ShowHide Related Items >><<
NUVA NuVasive
$56.40 /

-1.32 (-2.29%)

NUVA NuVasive
$56.40 /

-1.32 (-2.29%)

07/15/21 Piper Sandler
NuVasive MAGEC ship hold lift positive despite FDA warning, says Piper Sandler
05/06/21 Piper Sandler
NuVasive price target raised to $80 from $75 at Piper Sandler
04/27/21 Truist
NuVasive price target raised to $80 from $68 at Truist
04/05/21 Piper Sandler
FDA appears to approve NuVasive two-level indication, says Piper Sandler
NUVA NuVasive
$56.40 /

-1.32 (-2.29%)

Hot Stocks
NuVasive's announces new data on NuVasive Simplify Cervical Disc » 07:17
09/09/21
09/09
07:17
09/09/21
07:17
NUVA

NuVasive

$58.74 /

-0.965 (-1.62%)

NuVasive announced the…

NuVasive announced the NuVasive Simplify Cervical Disc one-level U.S. Food and Drug Administration Investigational Device Exemption study data was recently published in the International Journal of Spine Surgery. The data was utilized in the device's FDA pre-market application for one-level indication approval in September 2020. The peer-reviewed study reiterates that the Simplify Cervical Disc has a significantly greater success rate at the 24-month follow up compared to anterior cervical discectomy and fusion when used in treatment for one-level cervical total disc replacement. Findings from this study include: Mean Neck Disability Index, a patient-reported measure for disability related to cervical spinal disorders, was significantly lower for patients who underwent a cTDR with the Simplify Cervical Disc compared to ACDF; Range of motion significantly increased for cTDR patients treated with the Simplify Cervical Disc at three months and was maintained throughout follow ups; and Facet joint degeneration assessment by MRI showed little change from pre- to post-operation in the cTDR patients.

ShowHide Related Items >><<
NUVA NuVasive
$58.74 /

-0.965 (-1.62%)

NUVA NuVasive
$58.74 /

-0.965 (-1.62%)

07/15/21 Piper Sandler
NuVasive MAGEC ship hold lift positive despite FDA warning, says Piper Sandler
05/06/21 Piper Sandler
NuVasive price target raised to $80 from $75 at Piper Sandler
04/27/21 Truist
NuVasive price target raised to $80 from $68 at Truist
04/05/21 Piper Sandler
FDA appears to approve NuVasive two-level indication, says Piper Sandler
NUVA NuVasive
$58.74 /

-0.965 (-1.62%)

Hot Stocks
NuVasive appoints new CCO and CTO » 16:16
09/01/21
09/01
16:16
09/01/21
16:16
NUVA

NuVasive

$62.22 /

+0.04 (+0.06%)

NuVasive announced new…

NuVasive announced new executive leadership roles. Massimo Calafiore has been appointed Chief Commercial Officer and Ryan Donahoe has been appointed Chief Technology Officer. Since joining the company in 2017, Calafiore has held various leadership roles with increasing levels of responsibility, most recently serving as EVP, Global Business Units. Prior to NuVasive, he spent 16 years supporting and leading the U.S. business for Waldemar Link. During his 15 years at NuVasive, Donahoe has played an integral role in more than 20 issued and pending patents. In connection with this new leadership structure, Brent Boucher, EVP, Global Commercial, will transition from the company.

ShowHide Related Items >><<
NUVA NuVasive
$62.22 /

+0.04 (+0.06%)

NUVA NuVasive
$62.22 /

+0.04 (+0.06%)

07/15/21 Piper Sandler
NuVasive MAGEC ship hold lift positive despite FDA warning, says Piper Sandler
05/06/21 Piper Sandler
NuVasive price target raised to $80 from $75 at Piper Sandler
04/27/21 Truist
NuVasive price target raised to $80 from $68 at Truist
04/05/21 Piper Sandler
FDA appears to approve NuVasive two-level indication, says Piper Sandler
NUVA NuVasive
$62.22 /

+0.04 (+0.06%)

Over a month ago
Hot Stocks
NuVasive receives latest FDA 510(k) clearance for Pulse platform » 07:06
07/30/21
07/30
07:06
07/30/21
07:06
NUVA

NuVasive

$63.08 /

-2.24 (-3.43%)

NuVasive announced that…

NuVasive announced that it received its latest U.S. FDA 510(k) clearance for the Pulse platform, after receiving CE certification earlier this summer. In addition, the company announced the commercial launch of Pulse which is now available for sale in targeted global regions.

ShowHide Related Items >><<
NUVA NuVasive
$63.08 /

-2.24 (-3.43%)

NUVA NuVasive
$63.08 /

-2.24 (-3.43%)

07/15/21 Piper Sandler
NuVasive MAGEC ship hold lift positive despite FDA warning, says Piper Sandler
05/06/21 Piper Sandler
NuVasive price target raised to $80 from $75 at Piper Sandler
04/27/21 Truist
NuVasive price target raised to $80 from $68 at Truist
04/05/21 Piper Sandler
FDA appears to approve NuVasive two-level indication, says Piper Sandler
NUVA NuVasive
$63.08 /

-2.24 (-3.43%)

Earnings
NuVasive sees FY21 adjusted EPS $2.25-$2.35, consensus $2.20 » 16:12
07/28/21
07/28
16:12
07/28/21
16:12
NUVA

NuVasive

$65.43 /

-0.04 (-0.06%)

Sees FY21 revenue…

Sees FY21 revenue $1.19B-$1.21B, consensus $1.2B.

ShowHide Related Items >><<
NUVA NuVasive
$65.43 /

-0.04 (-0.06%)

NUVA NuVasive
$65.43 /

-0.04 (-0.06%)

07/15/21 Piper Sandler
NuVasive MAGEC ship hold lift positive despite FDA warning, says Piper Sandler
05/06/21 Piper Sandler
NuVasive price target raised to $80 from $75 at Piper Sandler
04/27/21 Truist
NuVasive price target raised to $80 from $68 at Truist
04/05/21 Piper Sandler
FDA appears to approve NuVasive two-level indication, says Piper Sandler
NUVA NuVasive
$65.43 /

-0.04 (-0.06%)

Earnings
NuVasive sees FY21 adjusted EPS $2.25-$2.35, consensus $2.20 » 16:12
07/28/21
07/28
16:12
07/28/21
16:12
NUVA

NuVasive

$65.51 /

+0.04 (+0.06%)

Sees FY21 revenue…

Sees FY21 revenue $1.19B-$1.21B, consensus $1.2B.

ShowHide Related Items >><<
NUVA NuVasive
$65.51 /

+0.04 (+0.06%)

NUVA NuVasive
$65.51 /

+0.04 (+0.06%)

07/15/21 Piper Sandler
NuVasive MAGEC ship hold lift positive despite FDA warning, says Piper Sandler
05/06/21 Piper Sandler
NuVasive price target raised to $80 from $75 at Piper Sandler
04/27/21 Truist
NuVasive price target raised to $80 from $68 at Truist
04/05/21 Piper Sandler
FDA appears to approve NuVasive two-level indication, says Piper Sandler
NUVA NuVasive
$65.51 /

+0.04 (+0.06%)

Earnings
NuVasive reports Q2 adjusted EPS 60c, consensus 44c » 16:11
07/28/21
07/28
16:11
07/28/21
16:11
NUVA

NuVasive

$65.51 /

+0.04 (+0.06%)

Reports Q2 revenue…

Reports Q2 revenue $294.8M, consensus $285.08M.

ShowHide Related Items >><<
NUVA NuVasive
$65.51 /

+0.04 (+0.06%)

NUVA NuVasive
$65.51 /

+0.04 (+0.06%)

07/15/21 Piper Sandler
NuVasive MAGEC ship hold lift positive despite FDA warning, says Piper Sandler
05/06/21 Piper Sandler
NuVasive price target raised to $80 from $75 at Piper Sandler
04/27/21 Truist
NuVasive price target raised to $80 from $68 at Truist
04/05/21 Piper Sandler
FDA appears to approve NuVasive two-level indication, says Piper Sandler
NUVA NuVasive
$65.51 /

+0.04 (+0.06%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.